Promising components developed to protect against cerebral palsy caused by oxygen deprevation at birth

Northwestern University chemists have developed two compounds that have been shown effective in pre-clinical trials in protecting against cerebral palsy due to oxygen deprivation during or shortly after birth.  The press release Stunning Finding: Compounds Protect Against Cerebral Palsy contains all the details, an excerpt of which is below:

"In developing the potential drugs, Silverman and his team were able to produce something that pharmaceutical companies so far have not: highly selective compounds that inhibit the enzyme found in brain cells that produces nitric oxide but that do not affect similar nitric oxide-producing enzymes found in endothelial and macrophage cells."

Scientists have not tested the compounds on humans yet, but the initial animal trials appear promising:

"None of the fetuses born to animals treated with the two compounds died; more than half of those born to untreated animals died. Eighty-three percent of animals treated with one of the compounds were born normal, with no cerebral palsy characteristics. Sixty-nine percent of animals treated with the other compound were born normal."

This research greatly interests me because our son has cerebral palsy caused by a lack of oxygen at birth.  Don't get me wrong, I love my son for who he is, but I am also in support of research that may help to minimize the long-term impacts of infant brain injury.